Document is current

Any future updates will be listed below

A comprehensive Review of Preclinical and Clinical Information on the Cardiovascular Advantages of SGLT2 Inhibitors

Crossref DOI link: https://doi.org/10.1007/978-981-97-7568-2_7

Published Online: 2024-11-16

Published Print: 2024

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark